4CPS-117 Relationship between daily dose frequency and adherence in chronic myeloid leukaemia

BACKGROUND: Adherence to tyrosine-kinase inhibitors (TKIs) treatment is regarded as one of the mainstays of chronic myeloid leukaemia (CML). PURPOSE: To analyse the variability in the adherence to TKIs treatment of CML in the function of the prescribed drug and evaluate how pharmaceutical care can i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Hosp Pharm
Asıl Yazarlar: Gil, S García, Casariego, GJ Nazco, Romero, MM Viña, Virginia, G, Alarcón, C, Piñero, M, García, J González, Nicolás, F Gutiérrez
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Group 2018
Konular:
Section 4: Clinical pharmacy services
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535459/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.208
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller